The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 176 (1), 35-44
- https://doi.org/10.1016/0014-2999(90)90129-t
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The role of CCK, caerulein, and CCK antagonists in nociceptionPain, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988
- Binding sites for 125I-cholecystokinin in primate spinal cord are of the CCK-A subclassNeuroscience Letters, 1988
- Classification and function of CCK receptorsTrends in Pharmacological Sciences, 1987
- Opiate Antagonistic Function of Cholecystokinin in Analgesia and Energy Balance SystemsaAnnals of the New York Academy of Sciences, 1985
- The Enhancement of Opiate Analgesia and the Possible Reversal of Morphine Tolerance by ProglumideaAnnals of the New York Academy of Sciences, 1985
- Potentiation of Opiate Analgesia and Apparent Reversal of Morphine Tolerance by ProglumideScience, 1984
- Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous systemPeptides, 1981
- Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)Neuropharmacology, 1980